patients with severe coronary artery stenosis (.701% occlusion in one or more coronary arteries or .50%o occlusion in the left main coronary artery), (2) patients with mild to moderate coronary artery stenosis (<70%o occlusion in one or more coronary arteries or <50%o occlusion in the left main coronary artery), and (3) patients with non-coronary heart disease or noncardiac chest pain (nonstenotic coronary arteries). The thermolability of methylenetetrahydrofolate reductase was prospectively determined in all subjects. Plasma homocyst(e)ine levels were then measured in those with thermolabile methylenetetrahydrofolate reductase. The traditional risk factors for coronary artery disease were thereafter ascertained by chart review of all subjects. The prevalence of thermolabile methylenetetrahydrofolate reductase was 18 .1% in group 1, 13.4% in group 2, and 7.9%o in group 3. There was a significant difference between the prevalence of thermolabile methylenetetrahydrofolate reductase in groups 1 and 3 (P<.04). All stored at -80°C until the preparation of enzyme extracts. The methods to determine methylenetetrahydrofolate reductase activity and thermolability were described previously.34-37 Based on our previous study,36 patients were classified as having thermolabile methylenetetrahydrofolate reductase when the residual activity was less than 20% after heat inactivation at 46°C for 5 minutes. Plasma homocyst(e)ine, serum folic acid, and cyanocobalamin levels were measured in all patients with thermolabile methylenetetrahydrofolate reductase. The methods for the determination of total plasma homocyst(e)ine, serum folic acid, and cyanocobalamin are described elsewhere.5,41
The differences between the three groups (ie, the patients with severe coronary stenosis, the patients with mild to moderate coronary artery stenosis, and the patients with nonstenotic coronary arteries) for The frequency of thermolabile methylenetetrahydrofolate reductase in patients with severe coronary artery stenosis, mild to moderate coronary artery stenosis, and angiographically normal coronary arteries was compared (Table 2 ). There was a significant difference between the incidence of thermolabile methylenetetrahydrofolate reductase in patients with severe coronary artery stenosis (group 1) and that in the controls (group 3) (P<.04). As in the case of the traditional risk factors, the prevalence of thermolabile methylenetetrahydrofolate reductase in patients with mild to moderate coronary artery stenosis (group 2) is intermediate between that in patients with angiographically severe coronary artery stenosis (group 1) and the control patients (group 3).
The risk factors (variables from Tables 1 and 2) were evaluated by a discriminant function analysis (Table 3) . Age, sex, hyperlipidemia history, diabetes mellitus, and gotes for cystathionine j3-synthase deficiency (0.35% to 1%) is considerably less than that of moderate hyperhomocyst(e)inemia (3% to 5%), implying the participation of a more common genetic defect in homocysteine metabolism or of nongenetic mechanisms to account for the association of hyperhomocyst(e)inemia with occlusive vascular disease.30 In a previous study,'6 thermolabile methylenetetrahydrofolate reductase was found in 5% of the normal population and was associated with moderate hyperhomocyst(e)inemia under physiological and normal nutritional conditions, suggesting that the majority of genetic hyperhomocyst(e)inemia was caused by thermolabile methylenetetrahydrofolate reductase. In addition, a statistically significant difference in the incidence of thermolabile methylenetetrahydrofolate reductase was previously demonstrated between patients with angiographically proven coronary artery disease and a normal population without clinical evidence of vascular disease.35'36 However, by documenting the status of the coronary arteries in all the subjects, including the controls, a stronger case may be made to support the positive association between thermolabile methylenetetrahydrofolate reductase and coronary disease.
In the present study, all subjects had coronary angiography to define their coronary anatomy. We demonstrated a positive association between severe coronary artery stenosis and the presence of thermolabile methylenetetrahydrofolate reductase. The association was independent of other risk factors. In addition, the strength of this association was obscured if patients with angiographically mild to moderate coronary artery stenosis were included either in the control group or in the group with severe coronary artery stenosis. When the analysis was limited to angiographically normal controls (group 1) and patients with severe coronary artery stenosis (group 3), thermolabile methylenetetrahydrofolate reductase and all of the known risk factors except family history of coronary artery disease were significantly related to coronary stenosis. Of additional interest is the fact that when thermolabile methylenetetrahydrofolate reductase was evaluated by discriminant function analysis, it was statistically related to coronary artery stenosis, whereas cigarette smoking, family history of coronary artery disease, and the serum cholesterol group were not statistically included in the model. Although the cholesterol level or group is significantly related to coronary stenosis when evaluated by univariate analysis without regard to other factors, the contribution of cholesterol group is no longer significant when other variables including thermolabile methylenetetrahydrofolate reductase also having a significant relation are analyzed by a multivariate technique.
The control subjects in this study were patients with noncoronary heart disease, such as valvular disease, cardiomyopathy, or noncardiac chest pain. In contrast, the majority of control patients in the previous study36 were clinically normal 
Conclusions
This study confirms that there is a positive association between thermolabile methylenetetrahydrofolate reductase and coronary artery stenosis; that thermolabile methylenetetrahydrofolate reductase is an independent risk factor of coronary artery stenosis; and that it is more closely related to coronary artery disease than some other well-recognized risk factors. Hence, thermolabile methylenetetrahydrofolate reductase should be added to the usual studies of risk factors in the assessment of patients for vascular disease, especially since it is potentially modifiable through nutritional means. 25, 3036 
